| Message: | CAS 38916-34-6 Somatostatin/sherry@chembj.com
Product Name: Somatostatin
Alias: Synthetic cyclic growth hormone release-inhibiting factor, Synthetic somatostatin-14,Somatostatin,Growth hormone release inhibiting factor
CAS: 38916-34-6
MF: C76H104N18O19S2
MW: 1637.88
Purity: 98.0%min
Grade: Pharmaceutical Grade
Appearance: White Powder
Single Impurity (HPLC): 1.0%max
Amino Acid Composition: ±10% of theoretical
Peptide Content (N%): ≥80.0%
Water Content (Karl Fischer): ≤8.0%
Acetate Content (HPIC): ≤15.0%
MS (ESI): Consistent
Specific Rotation (20/D): -37.0～-47.0°(c=1 1%HAc)
Mass Balance: 95.0~105.0%
Storage: Closed, below 2 ~ 8℃ preservation
Usage: Somatostatin regulates insulin and glucagon, and regulates the endocrine system and affects neurotransmission and cell proliferation.
Description
Somatostatin (also known as growth hormone-inhibiting hormone (GHIH) or somatotropin release-inhibiting factor (SRIF)) or somatotropin release-inhibiting hormone is a peptide hormone that regulates the endocrine system and affects neurotransmission and cell proliferation via interaction with G protein-coupled somatostatin receptors and inhibition of the release of numerous secondary hormones. Somatostatin regulates insulin and glucagon.
|
my account
